Curaleaf (CURLF) Holdings “applauds” the Trump Administration’s action to reschedule cannabis as a Schedule III substance under the Controlled Substances Act of 1970. “Curaleaf thanks President Trump for acting on his commitment to move forward with cannabis reclassification and we express our deep gratitude to him for this bold move. Moving the plant from Schedule I to Schedule III acknowledges what has been known for thousands of years, that the cannabis plant has medicinal properties. This policy shift by the United States government sets a precedent for how cannabis should be viewed globally and we eagerly await Attorney General Pam Bondi’s prompt execution of President Trump’s order,” said Boris Jordan, Chairman and CEO of Curaleaf.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf upgraded to Outperform from Sector Perform at ATB Capital
- Curaleaf Expands with Acquisition of Virginia Assets from The Cannabist Company
- Cannabist to sell Virginia assets to Curaleaf for $110M
- TLRY, CGC, CRON: Cannabis Stocks Jump as U.S. Medicare Considers Coverage
- Curaleaf Holdings’ Earnings Call: Mixed Sentiments with International Gains